Latest news for Franklin FTSE Australia ETF (ARCA:FLAU)

Franklin FTSE Australia ETF

Financial Services

Basic Materials

Healthcare

Real Estate

Energy

Consumer Cyclical

Industrials

Consumer Defensive

Communication Services

Technology

Utilities

Under normal market conditions, the Fund invests at least 80 percent of its assets in the component securities of the FTSE Australia Capped Index and in depositary receipts representing such securities. The FTSE Australia Capped Index is a free float-adjusted market capitalization weighted index maintained and calculated by FTSE Russell with a capping methodology applied quarterly to issuer weights so that no single issuer of a component exceeds 25 percent of the FTSE Australia Capped Index weight, and all issuers with weights above 5 percent do not cumulatively exceed 50 percent of the FTSE Australia Capped Indexs weight. The FTSE Australia Capped Index is based on the FTSE Australia Index and is designed to measure the performance of Australian large- and mid-capitalization stocks. FTSE Russell determines eligible securities for the FTSE Australia Capped Index based on measures such as the companys place of incorporation, listing country, investor protection regulations present in the country of incorporation, tax domicile, location of headquarters/factors of production and currency of denomination.

Commonwealth Bank Of Australia

Nuclear,Power,Plant,And,Technology.,Wide,Image,For,Banners,,Advertisements.

Government

News

Commodities

Global

Media

iShares MSCI New Zealand Investable Market Index Fund

ENZL

FLAU

Opposition proposes $211B nuclear power plan for Australia to boost economy, stabilize electricity, and reduce emissions, challenging ruling party.

Australian Opposition Goes Nuclear, $211 Billion Plan Could Open Doors For Uranium Miners

AtriCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.23) by 65.22 percent. This is a 61.9 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $124.300 million which beat the analyst consensus estimate of $121.842 million by 2.02 percent. This is a 16.67 percent increase over sales of $106.543 million the same period last year.

Earnings

Earnings Beats

ATRC

AtriCure Q4 2024 Adj. EPS $(0.08) Beats $(0.23) Estimate, Sales $124.300M Beat $121.842M Estimate

Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) shares traded higher on Wednesday after the company reported better-than-expected 2024 fiscal-year fourth-quarter earnings on Tuesday after <a href="https://www.benzinga.com//node/43642751">the market closed.</a>
What To Know: Confluent reported adjusted earnings per share of 9 cents, beating analysts&#8217; estimate of 6 cents. In addition, the company reported sales of $261.22 million, beating analysts&#8217; estimate of $256.83 million.
Confluent reported subscription revenue of $251 million, up 24% year-over-year. It also reported free cash flow of $29.1 million and an adjusted operating income of $13.6 million.
Confluent CFO Rohan Sivaram said the company has become &#8220;a major data platform&#8221; for the enterprise, with thousands of customers relying on its data streaming platform to &#8220;win in the era of cloud, data, and AI.&#8221;
&#8220;This has enabled an important combination of growth, scale, and double-digit expansion for both operating and free cash flow margins in 2024. Building on this momentum, we are well-positioned to achieve our growth and profitability targets for 2025.&#8221;
Analyst Changes: Following the earnings report, several analysts issued <a href="https://www.benzinga.com/25/02/43664034/confluent-analysts-increase-their-forecasts-after-upbeat-results">price target adjustments</a>.
<ul>
<li>Morgan Stanley analyst Sanjit Singh maintained an Equal-Weight rating on Confluent and raised the price target from&nbsp;$30&nbsp;to&nbsp;$32.</li>
<li>Truist Securities analyst Miller Jump maintained a Buy rating on Confluent and raised the price target from&nbsp;$35&nbsp;to&nbsp;$40.</li>
<li>UBS analyst Karl Keirstead maintained a Neutral rating on Confluent and raised the price target from&nbsp;$26&nbsp;to&nbsp;$34.</li>
<li>RBC Capital analyst Matthew Swanson maintained an Outperform rating on Confluent and raised the price target from&nbsp;$36&nbsp;to&nbsp;$41.</li>
</ul>
See Also: <a href="https://www.benzinga.com/insights/analyst-ratings/25/02/43670516/the-analyst-verdict-kilroy-realty-in-the-eyes-of-7-experts">The Analyst Verdict: Kilroy Realty In The Eyes Of 7 Experts</a>
Price Action: Confluent stock closed 22.5% higher at $36.87, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

CFLT

What's Going On With Confluent Shares Wednesday?

Financial Outlook The full year 2025 outlook information provided below is based on Corsair's current estimates and is not a guarantee of future performance. These statements are forward-looking and actual results may differ materially. Refer to the "Forward-Looking Statements" section below for information on the factors that could cause Corsair's actual results to differ materially from these forward-looking statements.
For the full year 2025, Corsair expects revenue growth to improve through the coming year, with a further improvement in adjusted EBITDA led by an additional improvement in margin, and a rebound in demand for the Company's high-performance gear for gamers, streamers, content-creators and gaming PC builders:
<ul>
<li>Net revenue to be in the range of $1.4 billion to $1.6 billion.</li>
<li>Adjusted operating income to be in the range of $67 million to $87 million.</li>
<li>Adjusted EBITDA to be in the range of $80 million to $100 million.</li>
</ul>
Certain non-GAAP measures included in our financial outlook were not reconciled to the comparable GAAP financial measures because the GAAP measures are not accessible on a forward-looking basis. We are unable to reconcile these forward-looking non-GAAP financial measures to the most directly comparable GAAP measures without unreasonable efforts because we are currently unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures for these periods but would not impact the non-GAAP measures. Such items may include stock-based compensation charges, amortization, and other items. The unavailable information could have a significant impact on our GAAP financial results.
The foregoing forward-looking statements reflect our expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially. We do not intend to update our financial outlook until our next quarterly results announcement.

Guidance

CRSR

Corsair Gaming Sees FY25 Net Revenue Forecasted Between $1.4B-$1.6B Vs $1.46B Est. ; Adjusted Operating Income $67M-$87M; Adjusted EBITDA $80M-$100M

5 analysts have expressed a variety of opinions on NetEase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $113.4, a high estimate of $122.00, and a low estimate of $105.00. This upward trend is apparent, with the current average reflecting a 3.85% increase from the previous average price target of $109.20.
<img src="https://www.benzinga.com/files/images/story/2025/1739394077_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive NetEase is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Poon</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$117.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Eddie Leung</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$122.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Alex Poon</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$108.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Alicia Yap</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Fawne Jiang</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$105.00</td>
<td>$120.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to NetEase. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of NetEase compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of NetEase's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of NetEase's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NTES/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on NetEase analyst ratings.</a>
<h2>Delving into NetEase's Background</h2>
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
<h3>Financial Insights: NetEase</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: NetEase's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -3.89%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Net Margin: NetEase's net margin excels beyond industry benchmarks, reaching 24.95%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): NetEase's ROE stands out, surpassing industry averages. With an impressive ROE of 4.97%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.55%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.08.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

NTES

The Analyst Verdict: NetEase In The Eyes Of 5 Experts

Ratings for Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $24.93, a high estimate of $31.00, and a low estimate of $19.00. A decline of 2.39% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1739394066_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Capri Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$23.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$28.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$29.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Simeon Siegel</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$31.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Announces</td>
<td>Buy</td>
<td>$30.00</td>
<td>-</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>-</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$23.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Oliver Chen</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$22.00</td>
<td>$57.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Capri Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Capri Holdings compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Capri Holdings's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Capri Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CPRI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Capri Holdings analyst ratings.</a>
<h2>Get to Know Capri Holdings Better</h2>
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
<h3>Capri Holdings: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Capri Holdings faced challenges, resulting in a decline of approximately -16.42% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Capri Holdings's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 2.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Capri Holdings's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.57%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Capri Holdings's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.36%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.34, Capri Holdings faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CPRI

A Glimpse Into The Expert Outlook On Capri Holdings Through 15 Analysts

In the latest quarter, 8 analysts provided ratings for S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $601.12, a high estimate of $633.00, and a low estimate of $576.00. Marking an increase of 1.27%, the current average surpasses the previous average price target of $593.57. 
<img src="https://www.benzinga.com/files/images/story/2025/1739394050_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of S&amp;P Global among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$600.00</td>
<td>$595.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$633.00</td>
<td>$617.00</td>
</tr>
<tr>
<td>David Motemeden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$608.00</td>
<td>$599.00</td>
</tr>
<tr>
<td>Jeffrey Silber</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$576.00</td>
<td>$564.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$617.00</td>
<td>$620.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$580.00</td>
<td>$590.00</td>
</tr>
<tr>
<td>Peter Christiansen</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Buy</td>
<td>$600.00</td>
<td>-</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$595.00</td>
<td>$570.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to S&amp;P Global. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of S&amp;P Global compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of S&amp;P Global's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into S&amp;P Global's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SPGI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on S&amp;P Global analyst ratings.</a>
<h2>Unveiling the Story Behind S&amp;P Global</h2>
S&amp;P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&amp;P's largest segment by profitability. S&amp;P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&amp;P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
<h3>S&amp;P Global's Financial Performance</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining S&amp;P Global's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 15.92% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: S&amp;P Global's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 27.16%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): S&amp;P Global's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.82%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): S&amp;P Global's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.6%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.35, S&amp;P Global adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPGI

Breaking Down S&P Global: 8 Analysts Share Their Views

Corsair Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSR#NASDAQ">CRSR</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.16 by 43.75 percent. This is a 4.55 percent increase over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $413.62 million which beat the analyst consensus estimate of $387.90 million by 6.63 percent. This is a 0.88 percent decrease over sales of $417.29 million the same period last year.

Corsair Gaming Q4 Adj $0.23 Beats $0.16 Estimate, Sales $413.62M Beat $387.90M Estimate

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Watts Water Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $223.5, a high estimate of $240.00, and a low estimate of $217.00. Observing a 8.67% increase, the current average has risen from the previous average price target of $205.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1739394042_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Watts Water Technologies by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Lee</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$217.00</td>
<td>$197.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$219.00</td>
<td>$218.00</td>
</tr>
<tr>
<td>Andrew Krill</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$240.00</td>
<td>-</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$218.00</td>
<td>$202.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Watts Water Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Watts Water Technologies compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Watts Water Technologies's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Watts Water Technologies's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WTS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Watts Water Technologies analyst ratings.</a>
<h2>Get to Know Watts Water Technologies Better</h2>
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, and heating systems; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. The company generates the majority of its revenue from markets in the Americas and in Europe, the Middle East, and Africa.
<h3>Watts Water Technologies's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Watts Water Technologies's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 7.79%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Watts Water Technologies's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 12.71%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Watts Water Technologies's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 4.18%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Watts Water Technologies's ROA stands out, surpassing industry averages. With an impressive ROA of 2.89%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.13.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Watts Water Technologies In The Eyes Of 4 Experts

In the latest quarter, 6 analysts provided ratings for Carlyle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $56.0, a high estimate of $60.00, and a low estimate of $52.00. Experiencing a 0.3% decline, the current average is now lower than the previous average price target of $56.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1739394035_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Carlyle Group. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$54.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$52.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$56.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$59.00</td>
<td>$57.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Carlyle Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Carlyle Group compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Carlyle Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Carlyle Group's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Carlyle Group analyst ratings.</a>
<h2>Unveiling the Story Behind Carlyle Group</h2>
The Carlyle Group is one of the world's largest alternative-asset managers, with $447.4 billion in total AUM, including $313.6 billion in fee-earning AUM, at the end of September 2024. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure, and natural resources funds (accounting for 33% of fee-earning AUM and 57% of base management fees during 2023), global credit (51% and 27%) and investment solutions (16% and 16%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 2,900 active carry fund investors from 88 countries.
<h3>Financial Insights: Carlyle Group</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Carlyle Group showcased positive performance, achieving a revenue growth rate of 106.34% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 46.02%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Carlyle Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.26% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.65%, the company showcases effective utilization of assets.
Debt Management: Carlyle Group's debt-to-equity ratio surpasses industry norms, standing at 1.67. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Carlyle Group In The Eyes Of 6 Experts

During the last three months, 7 analysts shared their evaluations of TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for TPG, presenting an average target of $73.14, a high estimate of $83.00, and a low estimate of $65.00. This current average reflects an increase of 10.1% from the previous average price target of $66.43. 
<img src="https://www.benzinga.com/files/images/story/2025/1739394013_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of TPG by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$66.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$78.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$73.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$83.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$77.00</td>
<td>$67.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to TPG. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of TPG compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of TPG's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of TPG's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TPG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on TPG analyst ratings.</a>
<h2>All You Need to Know About TPG</h2>
TPG Inc is an alternative asset firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, and Market Solutions. TPG aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment and performance of its portfolio.
<h3>A Deep Dive into TPG's Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining TPG's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 117.23% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: TPG's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 0.65%, the company may face hurdles in effective cost management.
Return on Equity (ROE): TPG's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.56%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): TPG's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.04%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: TPG's debt-to-equity ratio surpasses industry norms, standing at 1.84. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying TPG: Insights From 7 Analyst Reviews

Grail Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>) shares are trading higher Wednesday after the company announced <a href="https://www.benzinga.com/insights/analyst-ratings/25/01/43401565/what-6-analyst-ratings-have-to-say-about-quest-diagnostics">a new collaboration with</a> Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>).
The partnership aims to improve provider access to its <a href="https://www.benzinga.com/pressreleases/25/01/n42964119/patient-reported-outcomes-for-grails-galleri-multi-cancer-early-detection-blood-test-published-in-">Galleri multi-cancer early detection test. </a>
What To Know: The move is expected to streamline test ordering and expand availability across Quest's nationwide network, but investor reaction suggests concerns about the immediate impact on GRAIL's business.
GRAIL and Quest Diagnostics revealed the initial phase of their partnership, which allows physicians to order the Galleri test directly through Quest's connectivity system. This integration will enable over 500,000 providers to seamlessly request the test, just as they do with other blood work, through Quest's Quanum laboratory portal and more than 900 electronic health record systems. Patients can also access the test at any of Quest's 7,400 locations without needing to bring a test kit to their blood draw appointment.
Grail president Josh Ofman emphasized the significance of this expansion, noting that early detection is critical for improving cancer outcomes. 
He pointed out that while there are established screenings for only five cancers, nearly 70% of cancer-related deaths come from those without recommended screening tests. By integrating the Galleri test into routine exams, GRAIL and Quest aim to address this gap and make early detection more accessible.
Quest Senior Vice President Mark Gardner highlighted that the collaboration builds on their ongoing efforts since 2021 to expand access to the test. He stated that the new ordering process should simplify adoption among healthcare providers, making it easier to incorporate Galleri into standard cancer screening protocols.
The Galleri test detects cancer signals in the bloodstream by identifying DNA fragments shed by tumors, offering a non-invasive way to screen for multiple types of cancer before symptoms appear. The test is prescription-only and recommended for adults at elevated cancer risk, such as those over 50.
Price Action: Grail shares were up 17.6% at $38.63 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021225&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="523" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-1024x523.png" alt="" class="wp-image-779657" style="width:478px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-1024x523.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59.png 1536w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/02/43673047/gilead-ups-2025-outlook-eyes-lenacapavir-launch-for-hiv-prevention">Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention</a></li>
</ul>
Image Via Shutterstock.

GRAL

Grail Shares Spiked Wednesday: What's Going On?

The United States has released Alexander Vinnik, the Russian co-founder of the Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)-e cryptocurrency exchange, as part of a <a href="https://in.benzinga.com/news/global/25/02/43643471/trump-administration-secures-release-of-cannabis-prisoner-marc-fogel-from-14-year-russian-sentence">negotiated agreement with Moscow</a>.
What Happened: His release follows that of Marc Fogel, an American detained in Russia since 2021, The Wall Street Journal <a href="https://www.wsj.com/world/russian-bitcoin-exchange-co-founder-to-be-freed-by-the-u-s-after-americans-release-3f5fe066?mod=breakingnews">reported</a>.
Officials have characterized the move as part of ongoing diplomatic discussions rather than a direct prisoner swap.
Vinnik, who had been in U.S. custody in California, is now being transferred to Russia. 
His legal team confirmed that his family had been informed of the development. 
Vinnik was awaiting sentencing in the U.S. after pleading guilty to conspiracy to commit money laundering. 
Authorities had linked BTC-e to cybercriminal activities, including ransomware operations, identity theft and financial crimes.
Before his extradition to the U.S. in 2022, Vinnik was detained for five years in Greece and France following his 2017 arrest. 
Initially pleading not guilty, he later admitted to some charges in May 2024. 
His French attorney, Frédéric Bélot, expressed relief at his release, noting its significance for both Vinnik and his family.
The decision to release Vinnik was made a day after Marc Fogel returned to the U.S., where he was welcomed at the White House by President Donald Trump. 
Trump later stated that he had spoken with Russian President Vladimir Putin about broader geopolitical concerns, including efforts to bring an end to the war in Ukraine. 
He described the conversation as productive, stating that both leaders agreed on the need to prevent further loss of life.
Secretary of State Marco Rubio, when questioned about the agreement, denied that the U.S. had made significant concessions, stating that the deal did not involve releasing multiple individuals in exchange for Fogel's freedom.
In addition to Fogel's release, Radio Liberty confirmed that Belarusian journalist Andrey Kuznechyk had also been freed after more than three years in detention. 
The U.S.-funded news outlet credited diplomatic efforts for securing Kuznechyk's release, adding that he had reunited with his family in Lithuania.
The Kremlin acknowledged the deal, with spokesman Dmitry Peskov stating that negotiations had been conducted with careful deliberation.
He also noted that another Russian national would soon be released from U.S. custody, though he did not specify the individual.
While Peskov downplayed the idea of this deal being a major breakthrough, he said it contributed to rebuilding trust between Washington and Moscow.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43671255/will-donald-trump-help-broker-a-peace-deal-in-ukraine-dont-be-so-sure-polymarket-trader-say">Will Donald Trump Help Broker A Peace Deal In Ukraine? Don&#8217;t Be So Sure, Polymarket Trader Say</a>
Why It Matters: Unlike previous high-profile prisoner exchanges, such as the swap of WNBA player Brittney Griner for Russian arms dealer Viktor Bout, this agreement was carried out in stages rather than as a simultaneous exchange.
Trump, who has criticized past prisoner deals under the Biden administration, described this arrangement as fair and well-negotiated.
Vinnik's return to Russia makes it unlikely that he will face legal consequences in other countries that had been pursuing charges against him. U.S. prosecutors had accused him of running a large-scale money laundering operation through BTC-e, facilitating billions of dollars in illicit transactions between 2011 and 2017. 
His legal team had sought to argue for a reduced sentence in the U.S., citing the years he had already spent in detention abroad. However, his release means that he will not serve additional time in the American judicial system or face potential extradition elsewhere.
The releases of Vinnik, Fogel, and Kuznechyk highlight the ongoing diplomatic maneuvering between Washington and Moscow. 
While officials from both sides have framed these moves as signs of goodwill, it remains unclear whether this exchange will lead to further negotiations or influence broader geopolitical relations.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43667642/coinbase-expected-to-post-strong-earnings-as-trading-volume-hits-multi-year-high">Coinbase Expected To Post Strong Earnings As Trading Volume Hits Multi-Year High</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

US Releases Russian Bitcoin Exchange Co-Founder Alexander Vinnik In Prisoner Deal With Moscow

Macro Economic Events

Politics

Economics

General

President Trump Says Call With Russia's Putin Lasted Over One Hour; He And Putin Ultimately Expect To Meet, Probably In Saudi Arabia; Meeting With Putin Will Involve Saudi Crown Prince; Haven't Committed To Going To Ukraine; Don't Think It's Practical For Ukraine To Have NATO Membership; Putin Says He Wants The War To End And Not Go Back To Fighting 6-Months Later; Ukraine Has To Make Peace

Sports betting and iGaming company DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) could provide updated guidance after a Super Bowl outcome that may have been favorable to the sector when the company reports fourth-quarter financial results Thursday <a href="https://www.benzinga.com/earnings">after market close.</a>
 Earnings Estimates: Analysts expect DraftKings to report fourth-quarter revenue of $1.43 billion, up from $1.23 billion in last year's fourth quarter according to data <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021225&amp;t=be2bearmibe3na1">from Benzinga Pro.</a>
The revenue estimate would mark a record for the company and come after DraftKings missed analyst estimates for revenue in two straight quarters. The company has beaten revenue estimates in seven of the last 10 quarters.
Analysts expect DraftKings to report a loss of 15 cents per share in the fourth quarter, down from a profit of 29 cents in last year's fourth quarter. The company has been profitable in four of the last six quarters.
While DraftKings missed revenue estimates in recent quarters, the company has a streak of beating analyst earnings per share estimates in 11 straight quarters.
Read Also: <a href="https://www.benzinga.com/general/sports/25/02/43637086/super-bowl-lix-sets-viewership-record-how-many-watched-nfl-championship-kendrick-lamars-halftime">Super Bowl LIX Sets Viewership Record: How Many Watched NFL Championship, Kendrick Lamar&#8217;s Halftime</a>
What Analysts Are Saying: A new investor note from Bank of America calls Super Bowl LIX good for the sportsbooks like DraftKings.
While Super Bowl LIX won't factor into the fourth-quarter results, the big NFL event could factor into 2025 guidance and forward-looking commentary from the company.
"Big Game = Big win for the birds and the books," Bank of America said.
GeoComply, which verifies bettors locations, said reporting activity was up 14% year-over-year for Super Bowl LIX. Betting handle in New Jersey was up 19% year-over-year.
"We think the ability to grow double-digits during the biggest event of the year is impressive and could help assuage concerns of slowing handle."
Sportsbooks also benefitted from the Super Bowl LIX outcome according to the Bank of America note. As Benzinga previously reported, sportsbooks favored an outcome where the Eagles won and the over/under was under 48.5 points. While the point total hit the over, the Eagles won the game, ending many future bets on a Chiefs three-peat.
Sportsbooks may have also benefitted from player props with Saquon Barkley and Travis Kelce not getting touchdowns as two of the most bet on anytime TD players.
Bank of America estimates that Super Bowl LIX could add $20 million to $25 million of EBITDA to DraftKings for fiscal 2025.
The report said that DraftKings led the sports betting sector for downloads on Super Bowl Sunday and new download share.
While the report points to several positives for DraftKings, analysts at Bank of America see headwinds from higher taxes in some states and a lack of regulatory certainty on new state legalizations.
"Despite the solid start to 2025, we don't expect DKNG to raise their FY guidance given regulatory uncertainty."
Bank of America analyst Shaun Kelly has a Buy rating and $54 price target on DraftKings.
Here are the recent <a href="https://www.benzinga.com/quote/DKNG/analyst-ratings">analyst ratings on DraftKings</a> and their price targets:
<ul>
<li>Needham: Reiterated Buy rating, with $60 price target</li>
<li>TD Cowen: Maintained Buy rating, lowered price target from $55 to $51</li>
<li>Susquehanna: Maintained Positive rating, lowered price target from $56 to $54</li>
<li>Benchmark: Reiterated Buy rating, with $44 price target</li>
</ul>
Key Items to Watch: DraftKings fourth quarter includes the months of October, November and December, which is prime NFL season for bettors.
The company already <a href="https://www.benzinga.com/news/earnings/24/11/41826834/draftkings-q3-highlights-revenue-miss-2024-guidance-trim-first-2025-outlook-ceo-reaffirms-focus-on-">announced an adjustment </a>to its 2024 guidance due to some unfavorable periods of outcomes for the sportsbook that favored bettors for NFL games.
Investors and analysts will be looking to see how the final figures came out for the quarter and how much of an impact NFL favorites winning so many games had on the sportsbook.
Guidance for 2025 and positive commentary on Super Bowl LIX will likely be the items that could move the stock after earnings.
DraftKings could also share more color on how other sports outside of the NFL are performing and what the next few months without football could mean.
DKNG Price Action: DraftKings stock is up 3.5% to $28.69 on Wednesday versus a 52-week trading range of $28.69 to $49.57. DraftKings stock is up 3% over the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43608426/super-bowl-lix-rematch-again-sportsbooks-list-eagles-chiefs-as-top-favorites-for-super-bowl-lx">Super Bowl LIX Rematch Again? Sportsbooks List Eagles, Chiefs As Top Favorites For Super Bowl LX</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Sports Betting

Price Target

Previews

Reiteration

Trading Ideas

DKNG

DraftKings Q4 Earnings Preview: Analyst Says Super Bowl LIX = 'Big Win For The Birds And The Books'

On Wednesday,&nbsp;Biogen Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>)&nbsp;reported fourth-quarter adjusted EPS of $3.44, up 17%, beating&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">the consensus of $3.35</a>.
The company reported sales of $2.46 billion, up 2% year over year on constant currency and 3% on a reported basis, beating the <a href="https://www.benzinga.com/general/biotech/25/02/43659412/biogen-warns-lower-2025-revenue-inks-rd-funding-pact-with-royalty-pharma-for-late-stage-lupus-asset" target="_blank" rel="noreferrer noopener">consensus of $2.40 billion</a>.
As part of ongoing pipeline prioritization efforts, Biogen has decided to discontinue further development of BIIB113 in early Alzheimer&#8217;s disease, BIIB094 in early Parkinson&#8217;s disease, BIIB101 in multiple system atrophy, and BIIB143 (cemdomespib) in diabetic peripheral neuropathic pain.
Biogen forecasts a full-year 2025 adjusted EPS of $15.25-$16.25&nbsp;versus a consensus of $16.34.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42397286/biogen-downgraded-on-pipeline-setbacks-and-leqembi-sales-slowdown" rel="noreferrer noopener">Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown</a>
Revenue is expected to decline by a mid-single-digit percentage for 2025 compared to 2024 as further declines in multiple sclerosis product revenues are expected to be partially offset by increases in revenue from product launches.
Goldman Sachs analyst Salveen Richter notes that Biogen&#8217;s management expects to remain disciplined with regard to capital allocation, pointing to an interest in early-to-mid-stage deals in immunology, <a target="_blank" href="https://www.benzinga.com/quote/BIIB/analyst-ratings" rel="noreferrer noopener">rare diseases, and neurology</a>.
The analyst notes that while Goldman Sachs is mainly focused on Zurzuvae and Skyclarys, it is also watching for declines in the multiple sclerosis portfolio and Spinraza business. The main priority is how the company plans to counteract these losses through new product launches and business development.
Investors were especially concerned about the FY25 outlook compared to market expectations, particularly for Leqembi, and the company&#8217;s plans for mergers, acquisitions, and pipeline growth.
The analyst notes that for Leqembi&#8217;s rollout in early Alzheimer&#8217;s, the growth of infusion centers and more doctors prescribing it are major advantages. So far, Eli Lilly&#8217;s Kisunla has had little impact.
&#8220;We continue to watch market share vs. growth dynamics, and the extent to which the IV maintenance approval, the potential approvals of subcutaneous maintenance and induction, alongside the wider availability of blood-based biomarkers will drive launch momentum in 2025+,&#8221; Goldman Sachs analyst writes.
Price Action: BIIB stock is down 4.6% at $132.90 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43667099/crypto-for-a-cause-blackbaud-teams-up-with-the-giving-block-to-supercharge-nonprofit-donations" target="_blank" rel="noreferrer noopener">Crypto For A Cause: Blackbaud Teams Up With The Giving Block To Supercharge Nonprofit Donations</a></li>
</ul>
Photo: Tada Images/Shutterstock.com

Biotech

Large Cap

Health Care

BIIB

Biogen Delivers Q4 Beat, Analyst Focuses On Leqembi Expansion, 2025 Outlook

On Tuesday, Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) posted a fourth-quarter adjusted earnings per share loss of $2.16. That&#8217;s down from 11 cents a year ago, <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">in line with the consensus</a> and including <a href="https://www.benzinga.com/government/regulations/25/01/43173248/us-health-agency-cms-to-appeal-medicare-star-ratings-recalculation-ruling" target="_blank" rel="noreferrer noopener">incremental investments in Stars</a>.
The company reported revenues of $29.19 billion, up 13.5% year-over-year from $25.73 billion, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/25/02/43621782/insurance-giant-humanas-q4-earnings-at-par-with-estimates-2025-profit-outlook-falls-below-street-view" rel="noreferrer noopener">consensus of $28.84 billion</a>.
For 2025, Humana expects its insurance segment's benefit ratio guidance of approximately 90.1-90.5%.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/43321236/rfk-jr-and-big-pharma-stocks-to-watch-as-health-secretary-hopeful-answers-pointed-questions-on-drugs-insurance-trump-exec-orders" rel="noreferrer noopener">RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders</a>
Cantor Fitzgerald expects a more cautious approach to cost trend assumptions. However, analysts Sarah James and Gabie Ingoglia acknowledge the reasoning behind expecting some moderation.
&#8220;We have incremental concerns over outlier assumptions on cost trends though find some logic in the rationale, and we believe the Street may be underestimating the earnings power in turning around the group MA book in &#8217;26 and &#8217;27, which we estimate could represent a $1-2 earnings drag to 2025,&#8221; the analysts wrote.
Humana stands out by projecting a slowdown in the 2025 cost trend to the mid-single digits compared to the high-single digits in 2024. This contrasts with UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), Elevance Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>), and Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>), which anticipate continued elevated trends from 2024.
Humana attributes the expected slowdown to factors that won't repeat in 2025, such as the impact of the &#8220;two-midnight&#8221; rule, though it still expects high specialty drug costs. The company also noted stable cost trends from Q3 to Q4 2024, except for seasonal increases in supplemental benefits that drive year-end utilization.
Management plans to aggressively cut costs and AEP results confirm the company&#8217;s pricing strategy is working, analysts say. However, the company lost about 30,000 D-SNP members due to redetermination.
Another positive is that the PDP pricing strategy isn't facing issues.
Price Action: Humana stock is up 0.80% at $259.40 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/02/43662901/why-is-nano-cap-cancer-focused-xilio-therapeutics-stock-trading-over-100-on-wednesday" target="_blank" rel="noreferrer noopener">Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?</a></li>
</ul>
Image: Shutterstock

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Humana 2025 Outlook Shows Cautious Optimism Despite Industry Pressures

Whales with a lot of money to spend have taken a noticeably bearish stance on Arista Networks.
Looking at options history for Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) we detected 98 trades.
If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 52% with bearish.
From the overall spotted trades, 38 are puts, for a total amount of $4,749,194 and 60, calls, for a total amount of $3,836,100.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $75.0 and $160.0 for Arista Networks, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Arista Networks's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Arista Networks's whale activity within a strike price range from $75.0 to $160.0 in the last 30 days. 
<h3>Arista Networks Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739393128_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$10.9</td>
<td>$10.6</td>
<td>$10.61</td>
<td>$115.00</td>
<td>$1.7M</td>
<td>1.9K</td>
<td>2.3K</td>
</tr>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$33.6</td>
<td>$33.3</td>
<td>$33.3</td>
<td>$135.00</td>
<td>$253.0K</td>
<td>433</td>
<td>1</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.2</td>
<td>$5.9</td>
<td>$5.9</td>
<td>$150.00</td>
<td>$230.1K</td>
<td>201</td>
<td>480</td>
</tr>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$11.2</td>
<td>$11.1</td>
<td>$11.2</td>
<td>$97.50</td>
<td>$224.0K</td>
<td>340</td>
<td>212</td>
</tr>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$4.7</td>
<td>$4.6</td>
<td>$4.7</td>
<td>$102.50</td>
<td>$170.6K</td>
<td>2.6K</td>
<td>373</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
<h3>Where Is Arista Networks Standing Right Now?</h3>
<ul>
<li>With a volume of 11,124,561, the price of ANET is down -5.57% at $110.33. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 6 days.</li>
</ul>
<h3>Expert Opinions on Arista Networks</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $132.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Arista Networks, maintaining a target price of $135. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on Arista Networks with a target price of $130. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Arista Networks, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

ANET

Arista Networks Unusual Options Activity For February 12

Whales with a lot of money to spend have taken a noticeably bullish stance on Centrus Energy.
Looking at options history for Centrus Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LEU#AMEX">LEU</a>) we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 23% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $80,374 and 23, calls, for a total amount of $2,603,225.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $175.0 for Centrus Energy over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Centrus Energy's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Centrus Energy's whale activity within a strike price range from $60.0 to $175.0 in the last 30 days. 
<h3>Centrus Energy Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739393123_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LEU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$29.1</td>
<td>$27.6</td>
<td>$29.0</td>
<td>$100.00</td>
<td>$870.0K</td>
<td align="right">715</td>
<td align="right">504</td>
</tr>
<tr>
<td>LEU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$28.2</td>
<td>$25.8</td>
<td>$28.0</td>
<td>$100.00</td>
<td>$277.2K</td>
<td align="right">715</td>
<td align="right">100</td>
</tr>
<tr>
<td>LEU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$27.9</td>
<td>$27.8</td>
<td>$27.8</td>
<td>$100.00</td>
<td>$274.5K</td>
<td align="right">715</td>
<td align="right">200</td>
</tr>
<tr>
<td>LEU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$22.5</td>
<td>$22.1</td>
<td>$22.5</td>
<td>$130.00</td>
<td>$117.0K</td>
<td align="right">231</td>
<td align="right">115</td>
</tr>
<tr>
<td>LEU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$20.6</td>
<td>$19.8</td>
<td>$20.1</td>
<td>$175.00</td>
<td>$112.5K</td>
<td align="right">82</td>
<td align="right">103</td>
</tr>
</tbody>
</table>

<h3>About Centrus Energy</h3>
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
In light of the recent options history for Centrus Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Centrus Energy</h3>
<ul>
<li>With a trading volume of 952,792, the price of LEU is up by 3.4%, reaching $117.88.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 83 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Centrus Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Centrus Energy Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SOFI, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 35 uncommon options trades for SoFi Techs.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 34%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $482,886, and 26 are calls, for a total amount of $1,776,495.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $30.0 for SoFi Techs over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for SoFi Techs's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across SoFi Techs's significant trades, within a strike price range of $10.0 to $30.0, over the past month.
<h3>SoFi Techs Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739393118_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$4.65</td>
<td>$4.5</td>
<td>$4.6</td>
<td>$17.00</td>
<td>$193.1K</td>
<td>8.1K</td>
<td>1.1K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.75</td>
<td>$6.65</td>
<td>$6.75</td>
<td>$10.00</td>
<td>$168.7K</td>
<td>29.3K</td>
<td>692</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$2.22</td>
<td>$2.2</td>
<td>$2.21</td>
<td>$15.00</td>
<td>$110.2K</td>
<td>3.2K</td>
<td>91</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$7.25</td>
<td>$7.15</td>
<td>$7.25</td>
<td>$10.00</td>
<td>$106.5K</td>
<td>21.1K</td>
<td>164</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.05</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$15.00</td>
<td>$101.0K</td>
<td>14.9K</td>
<td>1.4K</td>
</tr>
</tbody>
</table>

<h3>About SoFi Techs</h3>
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
Following our analysis of the options activities associated with SoFi Techs, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of SoFi Techs</h3>
<ul>
<li>With a volume of 27,616,260, the price of SOFI is down -0.57% at $14.74. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 75 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SoFi Techs, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SOFI

Spotlight on SoFi Techs: Analyzing the Surge in Options Activity

WIIM

Silvercorp Metals shares are trading higher. The company reported Q3 financial results.

Australia's main opposition has proposed a $211 billion taxpayer-funded nuclear power plan. If successful, the turn to nuclear power would be a historic event for one of the largest <a target="_blank" href="https://www.benzinga.com/markets/commodities" rel="noreferrer noopener">global commodity producers</a>.



"Nuclear power will underpin the economic success of our country for the next century. This will make electricity reliable. It will make it more consistent. It will make it cheaper for Australians, and it will help us decarbonize," Peter Dutton, leader of the center-right Liberal Party, said <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-12-13/australia-s-opposition-reveals-211-billion-nuclear-power-plan" rel="noreferrer noopener">per</a> Bloomberg's report.



The country's approach to climate change has been politically charged, contributing to the downfall of former Prime Minister Scott Morrison in 2022. Australia remains one of the largest per-capita polluters globally, and Dutton's proposal directly challenges the ruling Labor Party's renewables-only strategy.



He called Labor's plan costly, citing claims that a balanced energy mix, including nuclear, would save taxpayers and businesses $167 billion. Australia has no operational nuclear power plants, as the industry was banned in 1998 under the Environment Protection and Biodiversity Conservation Act.&nbsp;



Despite Australia's position as the world's fourth-largest producer and holder of <a target="_blank" href="https://minerals.org.au/about/mining-facts/mineral-uranium/" rel="noreferrer noopener">one-third of global reserves</a>, uranium mining remains banned in Western Australia and Queensland. These restrictions persist even as the Minerals Council of Australia <a target="_blank" href="https://www.benzinga.com/government/24/08/40182376/uranium-explorers-call-for-lifting-mining-ban-in-western-australia-target-1b-in-exports" rel="noreferrer noopener">advocates for lifting bans</a> to help meet global clean energy demand.



Currently, the active uranium mining operations exist at just 3 locations:



<ul>
<li>Olympic Dam – the largest known deposit in the world, owned by BHP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>)</li>



<li>Four Mile &#8211; a high-grade mine owned by Quasar Resources.</li>



<li>Ranger (Northern Territory) &#8211; controlled by Rio Tinto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>), but at the end of its lifespan.</li>
</ul>



Dutton's plan includes constructing seven nuclear power plants by 2050, with the first operational by 2036. If it goes through, it would be reasonable to expect the removal of mining restrictions, presenting opportunities for domestic and foreign uranium explorers. If Western Australia lifts the mining ban, operators like Toro Energy and Paladin Energy could pursue <a target="_blank" href="https://www.dmp.wa.gov.au/Uranium-1459.aspx" rel="noreferrer noopener">multiple regional projects</a>.



The largest publicly traded uranium producer, Cameco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>), owns the Yeelirrie project in the region, which it acquired from BHP in 2012.



Volatile energy costs in Australia have been an issue exaggerated by significant regional disparities. In October, The Guardian <a target="_blank" href="https://www.theguardian.com/australia-news/2024/oct/18/energy-prices-soar-after-volatile-wind-saw-heavier-gas-hydro-and-battery-use-australian-regulator-says" rel="noreferrer noopener">reported</a> a price of $114/MWh in Queensland compared to $201/MWh in South Australia, as high transmission costs can constitute 40% of an energy bill.



A network of strategically placed nuclear power plants would help solve this problem, reducing the cost of commodity production and further strengthening the Australian industry. As the 2025 general elections draw closer, nuclear power and uranium mining will likely become important topics down under.



Read Next:



<ul>
<li><a href="https://www.benzinga.com/24/12/42433867/lithium-producers-brace-for-prolonged-oversupply-stalled-prices" target="_blank" rel="noreferrer noopener">Lithium Producers Brace For Prolonged Oversupply, Stalled Prices</a></li>
</ul>



Photo by metamorworks via Shutterstock

Comments

Franklin FTSE Australia ETF

News

Latest news for Franklin FTSE Australia ETF (ARCA:FLAU)

Friday, December 13, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga